Abstract Library

#4186 The effect of the Covid-19 pandemic on the body composition of patients with gastroenteropancreatic neuroendocrine tumors using a somatostatin analogue

Introduction: The Covid-19 pandemic and its restrictions had a negative impact on the general population. Due to lockdowns, food intake increased and exercise decreased. This led to weight gain and changes in body composition. Hospitals reviewed patients (pts) remotely. The effect of the Covid-19 pandemic has not been described in pts with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with somatostatin analogue (SSA).

Conference:

Presenting Author: Clement D

Authors: Clement D, Brown S, Dolly S, Mestre-Alagarda C, Giovos G,

Keywords: GEP-NET, SSA, malnutrition, Covid-19 pandemic,

#3874 Ileum NET lost to follow-up due to COVID-19 pandemic presents with multiple metastases and severe carcinoid syndrome

Introduction: Small bowel neuroendocrine tumors (NETs) arise from the diffuse neuroendocrine system. These are often diagnosed as a result of acute symptomatology such as bowel obstruction and are the most common cause of carcinoid syndrome (CS) due to liver metastases (LM).

Conference:

Presenting Author:

Authors: Diculescu R, Becheanu G, Croitoru A, Poiana C,

Keywords: neuroendocrine tumor, carcinoid syndrome, carcinoid heart disease, Octreotide,

#3839 The impact of the COVID-19 pandemic on neuroendocrine tumor (NET) service recovery and patient perceptions in Sheffield NET Centre UK – A quantitative and qualitative analysis 2017-2021

Introduction: The COVID-19 pandemic has affected the delivery of NET services and patient care. To assess the evolution of NET services during and peri-pandemic, we retrospectively analysed NET services and patient perceptions between 2017-2021.

Conference:

Presenting Author: Munir A

Authors: Munir A, Dabke T, Finnen J,

Keywords: COVID-19, NET, Service, Patient Satisfaction, Therapy, Psychology,

#3674 COVID-19 in patients with neuroendocrine neoplasms – Two-year results of a worldwide survey (The INTENSIVE study)

Introduction: Preliminary results regarding 85 patients of the INTENSIVE study have been published in 2021.

Conference:

Presenting Author: Gervaso L

Authors: Fazio N, Gervaso L, Halfdanarson T, Sonbol M, Pusceddu S,

Keywords: neuroendocrine, NEN, COVID-19, SARS-CoV-2,

#3628 Retrospective survival analysis of patients with small bowel neuroendocrine tumors (NETs) and analysis of patient satisfaction post covid pandemic in the Sheffield European Neuroendocrine Tumor Society (ENETS) Centre of Excellence (COE)

Introduction: Small bowel NETs are the commonest primary malignancies of the small bowel. Incidence is increasing, but it is often still diagnosed at a late stage. The effects of COVID-19 may have affected patient satisfaction. Reported survival is quoted at 90% at 1 year and 70% at 5 years for all stages.

Conference:

Presenting Author:

Authors: Kwok W, Finnen J, Munir A,

Keywords: Neuroendocrine, cell, research, Neuroendocrine tumor, Survival analysis, patient satisfaction,